At a glance
ClinicalIndex Comparison RecordN/ACompleted· 173 enrolled
Drug / intervention
INVSENSOR00026device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Hemodilution Validation of INVSENSOR00026
In Brief
A clinical study evaluating INVSENSOR00026 for Healthy. Completed, enrolled 173 participants across 1 site.
Detailed Summary
In this study, the concentration of hemoglobin within the subject's blood will be reduced in a controlled manner by administering fluids intravenously. The accuracy of a noninvasive hemoglobin sensor will be assessed by comparison to hemoglobin measurements from a laboratory analyzer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartSep 2018
First PostedSep 2018
Primary CompletionFeb 2019
TodayJul 2026
First PostedSep 19, 2018
Enrollment StartSep 4, 2018
Primary CompletionFeb 4, 2019
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 7.8 years ago
Interventions
INVSENSOR00026device
Noninvasive pulse oximeter sensor